Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239694 · ClinicalTrials.gov registry record · Phase 4
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
A Phase 4 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00239694 is a Phase 4 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 100 participants.
The verdict
NCT00239694, a Phase 4 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.
Interventions
- BIOLOGICAL Pneumococcal Vaccine
- BIOLOGICAL Meningococcal Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-04 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00239694
The ClinicalTrials.gov registry entry for NCT00239694 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pneumococcal Vaccine is the first listed.
NCT00239694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00239694 about?
NCT00239694 is a clinical study titled "PPV: Pneumococcal Polysaccharide Vaccine in Older Adults". The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.
What is the current status of trial NCT00239694?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-04. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00239694?
The interventions under investigation include: Pneumococcal Vaccine (BIOLOGICAL), Meningococcal Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00239694?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.